SH

Steve Harvey

CEO

Camena Bioscience

Cambridge, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Camena Bioscience
Industry
research
Employees
30.0
Seniority
C suite
Total Funding
10000000.0
Latest Funding
Series A

Technologies

Gmail Google Apps CloudFlare Hosting Hubspot Mobile Friendly Facebook Widget Google Tag Manager Linkedin Widget Ruby On Rails Typekit Varnish Facebook Login (Connect) Linkedin Login Google Font API Android

Keywords

dna synthesis complex genes synthetic biology synbio gene synthesis biotechnology research synthetic genes gsynth platform high-throughput dna production enzyme-based dna synthesis mrna vaccines gene-length dna personalized medicine crispr technology bioinformatics design green synthesis complex dna sequences cell & gene therapies sustainability in biotech proprietary enzyme technology templated mrna production sequence optimization biotechnology innovation therapeutic applications pharmaceutical industry support template dna bottleneck accuracy in synthesis genome editing environmental impact reduction multiplex crispr editing gene assembly healthcare sector emissions high-value therapeutic programs de novo synthesis molecular biology solutions sequence integrity scientific collaboration research breakthroughs automated dna synthesis codon optimization extracellular vesicles dna verification therapeutics development nucleotide synthesis challenges biological constructs supply chain security environmentally friendly methods gene editing efficiency bioengineering clinical trial innovations molecular diagnostics production scalability biotechnology

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans